Document Detail


Long-term anabolic therapy in the elderly.
MedLine Citation:
PMID:  413345     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The anabolic agent stanozolol has been used to increase weight and activity in the elderly, but its long-term effect are largely unknown. A double-blind trial of stanozolol against placebo was continued for 12 months. Measuremtnes of weight, fat, fat-free mass, behaviour and activity were made at regular intervals, plus detailed biochemical and haematological profiles. There were no differences between the two groups in respect of weight, fat, fat-free mass and activity levels. There were significant increases in haemoglobin at six and 12 months and packed cell volume at 12 months in the active group. No androgenic side-effect were encountered.
Authors:
M D Lye; A E Ritch
Related Documents :
22818465 - Effect of prepartum maternal energy density on the growth performance, immunity, and an...
10961485 - Changes of bioelectrical impedance after a body weight reduction program in highly obes...
16740375 - Annual fat mass change is a significant predictor of mortality in female hemodialysis p...
11978675 - Five-week, low-glycemic index diet decreases total fat mass and improves plasma lipid p...
20453305 - Associations of atgl gene polymorphisms with chicken growth and fat traits.
1734685 - Metabolic advantages of spreading the nutrient load: effects of increased meal frequenc...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article    
Journal Detail:
Title:  Age and ageing     Volume:  6     ISSN:  0002-0729     ISO Abbreviation:  Age Ageing     Publication Date:  1977 Nov 
Date Detail:
Created Date:  1978-02-18     Completed Date:  1978-02-18     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0375655     Medline TA:  Age Ageing     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  221-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Activities of Daily Living
Aged
Body Composition / drug effects
Body Weight / drug effects
Clinical Trials as Topic
Double-Blind Method
Female
Geriatrics*
Hematocrit
Hemoglobinometry
Humans
Long-Term Care
Male
Protein Biosynthesis
Skinfold Thickness
Stanozolol / therapeutic use*
Chemical
Reg. No./Substance:
10418-03-8/Stanozolol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Alcohol withdrawal reactions in rhesus monkeys.
Next Document:  Thiamine dependency in a patient with congenital lacticacidaemia due to pyruvate dehydrogenase defic...